Komal Gupte-Singh
1PUBLICATIONS
3CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (1)
Sort by Publication Date:
|Mar 31, 2023
Cost Per Relapse Avoided for Ozanimod Versus Other Selected Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis in the United States.Daniel Kantor, Timothy Pham, Oscar Patterson-Lomba
Pageof 1
